PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer
- First Posted Date
- 2010-05-12
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 70
- Registration Number
- NCT01121575
- Locations
- 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
🇺🇸Drug Shipment Only, Boston, Massachusetts, United States
🇺🇸Clinical Trials Office University of Colorado Hospital (CTO), Aurora, Colorado, United States
Study To Assess The Effect Of Gabapentin, Diphenhydramine And Morphine On Cold Pain In Healthy Male Volunteers
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2010-05-07
- Last Posted Date
- 2011-03-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 19
- Registration Number
- NCT01119222
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
A Study To Observe The Performance Of A Tablet Form Of PF-04531083 As Evidenced By The Concentration Of PF-04531083 In The Blood With Time Following Oral Administration To Healthy Volunteers.
- First Posted Date
- 2010-05-07
- Last Posted Date
- 2010-08-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT01119235
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
Study To Assess The Reproducibility And Sensitivity Of Quantitative Sensory Testing In Patients With Neuropathic Pain
- First Posted Date
- 2010-05-05
- Last Posted Date
- 2019-04-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 31
- Registration Number
- NCT01117766
- Locations
- 🇬🇧
Pfizer Investigational Site, London, United Kingdom
Study In Healthy Adult Volunteers To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429
- First Posted Date
- 2010-05-05
- Last Posted Date
- 2012-01-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 40
- Registration Number
- NCT01117233
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects
- Conditions
- Growth Hormone Deficiency
- Interventions
- Device: Genotropin PenDevice: MARK VII pen
- First Posted Date
- 2010-04-28
- Last Posted Date
- 2012-05-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 120
- Registration Number
- NCT01112865
- Locations
- 🇸🇪
Barn och Ungdomsmedicinkliniken, Linkoping, Sweden
🇬🇧Salford Royal NHS Foundation Trust, Hope Hospital, Salford, Manchester, United Kingdom
🇨🇿Fakultni nemocnice v Motole, Praha 5, Czech Republic
Child Pneumococcal Serotype Epidemiology In Greece
- Conditions
- Pneumococcal Disease
- Interventions
- Other: no intervention
- First Posted Date
- 2010-04-27
- Last Posted Date
- 2013-01-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 457
- Registration Number
- NCT01111214
- Locations
- 🇬🇷
Agia Sophia Children's Hospital, Athens, Attiki, Greece
🇬🇷University Hospital of Alexandroupolis, Alexandroupoli, Greece
🇬🇷University Hospital of Herakleion, Herakleion, Greece
A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers
- Conditions
- Pulmonary DiseaseLung DiseaseMoxifloxacin
- Interventions
- First Posted Date
- 2010-04-20
- Last Posted Date
- 2011-01-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 48
- Registration Number
- NCT01107054
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors
- Conditions
- Neoplasm
- Interventions
- Drug: PF-00337210
- First Posted Date
- 2010-04-16
- Last Posted Date
- 2013-03-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 46
- Registration Number
- NCT01105533
- Locations
- 🇺🇸
Pfizer Investigational Site, Madison, Wisconsin, United States
Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa
- Conditions
- Asymptomatic Parasitemia In Pregnancy
- Interventions
- First Posted Date
- 2010-04-15
- Last Posted Date
- 2015-01-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 168
- Registration Number
- NCT01103713
- Locations
- 🇰🇪
Siaya District Hospital, Siaya, Kenya
🇹🇿Teule Hospital, Muheza, Tanga, Tanzania
🇧🇯Centre de Sante d'AHOUANSORI -AGUE, Cotonou, Benin